Patents

Strengthening our portfolio of patents

Imugene continues to focus on the expansion and protection of its intellectual property (IP) portfolio. This incorporates both the extension of patents to include developments in our product range, as well the jurisdictions in which they are covered. By doing so, we expand the possible applications for our technology.

In late 2008, two important patent applications were lodged, one for a pig vaccine and one for a poultry vaccine. Consistent with our international approach to our IP, these patents were first lodged in the US and will be extended to other territories. The content of these two patents is confidential, however both diseases targeted are major disease and the patent applications extend well beyond our adenoviral delivery technology.

Poultry Adenovirus Patents (FAV) (19821 Family)

Country/Jurisdiction Patent/Application No. Status
United States 6296852 Granted
Australia 676042 Granted
New Zealand 263772 Granted
Europe 690912 Granted; Validated in Germany, Great Britain, France, Italy, Belgium, The Netherlands
Japan 6522542 Granted
Europe 5076351.5 Pending

Pig Adenovirus Patents (PAV) (19814 Family)

Country/Jurisdiction Patent/Application No. Status
United States 7323177 Granted
United States 7473428 Granted
United States 12/197056 Granted
United States 6492343 Granted. Reissue filed (11/518,612) and Notice of Allowance received
New Zealand 503039 Granted
Europe 1007088 Granted; Validated in Austria, Belgium, Switzerland, Cyprus, Germany, Denmark, Spain, Finland, France, Great Britain, Greece, Ireland, Italy, Luxembourg, Monaco, The Netherlands, Portugal and Sweden
Japan 2000-509443 Pending
Vietnam 4355 Granted
Brazil 98111841 Pending
China 910366292 Granted
Hong Kong 1032755 Granted
Indonesia 0014936 Granted
Korea 746524 Granted
Mexico 2000-001562 Pending
United States 11/518,612 Pending
Australia 0757683 Granted
Europe 07005454.9 Pending

Methods and Compositions for Increasing Tissue Tropism of Recombinant Vectors (19822 Family)

Country/Jurisdiction Patent/Application No. Status
Argentina 070103361 Pending
PCT PCT/IB07/002710 Pending
Taiwan 096127865 Pending
Australia 2007278887 Pending
Brazil N/A Pending
Canada 2,658,805 Pending
China 200780026689.3 Pending
Europe 07804942.6 Pending
Japan 2009-521375 Pending
Korea 10-2009-7003405 Pending
Mexico MX/a/2009/000898 Pending
United States 12/373,772 Pending

Novel Avian Cytokines and Genetic Sequences Encoding Same (‘Chicken Gamma Interferon’) (derived from PCT/AU96/00114)

Country/Jurisdiction Patent/Application No. Status
United States 6642032 / 6083724 Granted
Australia 689028 Granted
New Zealand 302188 Granted
Europe 96903831.4 Under prosecution (Office action filed)
Canada 2214453 Under prosecution (Office action filed)
Mexico 976735 Granted

PCV 2-Based Methods and Compositions for the Treatment of Pigs

Country Number Status
United States (provisional; due for PCT filing in 12/09) 61/122,555 Pending

Methods and Compositions for Use of a Coccidiosis Vaccine

Country Number Status
United States (provisional; due for PCT filing in 12/09) 61/122,596 Pending